CIK 1508053
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2016-Q1. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 75.24% | 1 |
| Unclassified | 24.76% | 3 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | AGIO | AGIOS PHARMACEUTICALS, INC. | Health Care | 75.24% |
| 2 | SELECTA BIOSCIENCES INC | Unclassified | 21.50% | |
| 3 | SESEN BIO, INC. | Unclassified | 2.98% | |
| 4 | RENEWABLE ENERGY GROUP INC | Unclassified | 0.28% |
1/4 names classified · sector 75.2% of weight · industry 75.2% · mkt cap 75.2%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 75.2% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/2 names) · unclassified 100.0%: AGIO, . Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | AGIOAGIOS PHARMACEUTICALS INC | 1,930,369 | $81M | 75.2% | NEW |
| 2 | SELECTA BIOSCIENCES INC | 1,651,862 | $23M | 21.5% | NEW |
| 3 | SESEN BIO, INC. | 1,907,008 | $3M | 3.0% | NEW |
| 4 | RENEWABLE ENERGY GROUP INC | 33,570 | $296,000 | 0.3% | NEW |
Where this firm's principals came from and which firms its alumni went on to found.
